Liraglutide vs Semaglutide: The Molecular Difference Liraglutide (Saxenda): First-generation GLP-1 agonist for weight loss Approximately 97% amino acid similarity to natural GLP-1 Half-life of approximately 13 hours Requires daily injection to maintain blood levels Semaglutide (Ozempic, Wegovy): Second-generation GLP-1 agonist Modified structure for greater potency and longer action Half-life of approximately 7 days Weekly injection maintains stable blood levels The structural modifications in semaglutide make it bind more effectively to GLP-1 receptors and resist breakdown longer
Modlinger P, Chabrashvili T, Gill PS, Mendonca M, Harrison DG, Griendling KK, et al
Injectable semaglutide, sold by Novo Nordisk under the brand name Wegovy for weight loss, and tirzepatide, sold by Eli Lily as Zepbound for weight loss, generally cap out at a 15-20% body weight loss for the highest doses and 5-10% on the lower end
iii According to the CDC, the rate of suicide among teens between the ages of 10 to 24 increased nearly 60% between 2007 and 2018
The safety, efficacy and quality of such preparations cannot be verified owing to their dubious origin and lack of regulatory control
However, your healthcare provider may prescribe microdosing depending on your body tolerance
